- Home
- UCL vs ALEC Comparison
UCL vs ALEC Comparison
Compare UCL & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- ALEC
- Stock Information
- Founded
- UCL 2014
- ALEC 2013
- Country
- UCL Hong Kong
- ALEC United States
- Employees
- UCL N/A
- ALEC N/A
- Industry
- UCL Telecommunications Equipment
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UCL Consumer Discretionary
- ALEC Health Care
- Exchange
- UCL Nasdaq
- ALEC Nasdaq
- Market Cap
- UCL 144.5M
- ALEC 124.0M
- IPO Year
- UCL 2020
- ALEC 2019
- Fundamental
- Price
- UCL $2.70
- ALEC $2.80
- Analyst Decision
- UCL
- ALEC Buy
- Analyst Count
- UCL 0
- ALEC 8
- Target Price
- UCL N/A
- ALEC $4.50
- AVG Volume (30 Days)
- UCL 169.9K
- ALEC 1.2M
- Earning Date
- UCL 08-13-2025
- ALEC 11-05-2025
- Dividend Yield
- UCL N/A
- ALEC N/A
- EPS Growth
- UCL N/A
- ALEC N/A
- EPS
- UCL 0.02
- ALEC N/A
- Revenue
- UCL $89,277,000.00
- ALEC $81,130,000.00
- Revenue This Year
- UCL N/A
- ALEC N/A
- Revenue Next Year
- UCL $20.86
- ALEC $196.86
- P/E Ratio
- UCL $123.88
- ALEC N/A
- Revenue Growth
- UCL 3.72
- ALEC 46.77
- 52 Week Low
- UCL $0.80
- ALEC $0.87
- 52 Week High
- UCL $4.19
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- UCL 42.17
- ALEC 64.59
- Support Level
- UCL $2.84
- ALEC $2.30
- Resistance Level
- UCL $3.20
- ALEC $3.07
- Average True Range (ATR)
- UCL 0.38
- ALEC 0.21
- MACD
- UCL -0.13
- ALEC 0.03
- Stochastic Oscillator
- UCL 11.88
- ALEC 73.96
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.